Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.
U Power is an intelligent electric vehicle company based in Xuhui District, Shanghai, China. Founded in 2021, the company focuses on developing vehicles tailored for specific scenarios, allowing clients to customize cars through its standardized UP super chassis. U Power aims to facilitate the implementation of Car as a Service (CaaS) capabilities, empowering clients to integrate automotive solutions into their projects effectively.
Guangdong Xinyue
Series A in 2024
Xinyueneng manufactures silicon carbide chips and conducts research and development in the automotive and industrial control industries.
GasGene
Seed Round in 2024
GasGene ferments industrial waste gas to generate bulk chemicals.
Jiuyou Airlines
Series A in 2023
Jiuyou aircraft is a high-tech company specializing in the research and development, manufacturing, and after-sales support of aircraft parts and composite products.
Rigen Biotech
Series B in 2023
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
Minieye is a technology company focused on developing advanced vehicle visual sensing systems aimed at enhancing road safety and driver awareness. Its innovative system detects a variety of traffic objects, such as vehicles, pedestrians, lanes, and traffic signals, while also utilizing in-cabin sensing technology to monitor the conditions and behaviors of drivers and passengers. By analyzing factors like eyelid movement, gaze direction, and body position, Minieye seeks to improve the safety of all vehicle occupants. The company's solutions leverage deep learning algorithms to ensure robust performance even in challenging environmental conditions, such as adverse weather and varying light levels. Ultimately, Minieye's mission is to reduce traffic accidents and advance the automation of vehicles, contributing to safer driving experiences.
AIMIRA Innovation Technology
Seed Round in 2023
AIMIRA Innovation Technology is an AI-based medical technology company that offers diagnosis, aesthetic plastic surgery, and anti-aging medicine.
DeepKinase
Series A in 2023
DeepKinase is a biotechnology company that specializes in clinical proteomics, focusing on the diagnosis of tumor, immune, and neurodegenerative diseases. The company leverages its proprietary Deep Omics of Tyrosine Kinase (DoTK) platform, which is based on patented proteomics technology. By utilizing advanced proteomics techniques, DeepKinase aims to provide more accurate and precise diagnostic solutions for complex diseases, enhancing the understanding and treatment options available for patients. Through its innovative approach, the company seeks to advance the field of proteomics and improve clinical outcomes.
AutoCore is a provider of intelligent mobility software and automotive electrical and electronic architecture solutions. The company specializes in developing an automotive middleware platform designed to support next-generation vehicles. Its offerings include operating systems and autonomous driving software tailored for various automotive computing platforms. AutoCore assists Original Equipment Manufacturers (OEMs) and Tier 1 suppliers throughout the entire product life cycle, from design to production, ensuring that automotive innovations meet the evolving demands of the industry.
Shiyu Technology
Seed Round in 2023
Shiyu Technology specialized in innovative research and development of automotive thermal domain control systems. Its products and services include thermal management, heat pumps, air conditioning, and cloud-based data and control algorithms.
Guangdong Xinjuneng
Series C in 2022
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.
Health Gene Technologies
Series C in 2022
Health Gene Technologies provides premium solutions for multiplexed nucleic acid detection. Based on the high-resolution Capillary Electrophoresis (CE) Platform, HGT has independently developed a series of nucleic acid testing products, established a set of matured clinical nucleic acid testing solutions. Health Gene Technologies provides complete testing solutions for forensic DNA samples. It includes reagents and equipment required in the entire laboratory process.
Innogen Pharmaceutical
Venture Round in 2022
Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.
SiEngine Technology
Series A in 2022
SiEngine Technology is a developer of electronic chips specifically designed for the automotive industry. The company focuses on creating advanced System on a Chip (SoC) solutions for smart cockpits and autonomous driving applications. By integrating innovative technologies into its products, SiEngine aims to enhance the driving experience, providing drivers with intelligent features that support modern automotive needs. Through its commitment to developing high-performance control chips, SiEngine Technology plays a significant role in the evolution of vehicle electronics, contributing to the advancement of smart and autonomous vehicles.
Yuce Biotechnology
Series A in 2022
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.
Yueer Gene
Series B in 2022
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.
Brise Pharma
Seed Round in 2022
Brise Pharma is a scientific research company specializing in developing novel biopharmaceutical drugs for treating pain. Its primary focus lies in creating innovative and distinct analgesic treatments targeting migraine, neuropathic, and musculoskeletal pain, aiming to provide safe, effective, and accessible pain relief solutions globally.
Black Sesame Technologies
Venture Round in 2022
Black Sesame Technologies is an AI digital imaging technology firm that develops solutions for real-world AI challenges, focusing on image processing and embedded sensing platforms. Established in 2016 and headquartered in Silicon Valley and Shanghai, the company specializes in creating algorithms for applications in smartphones, autonomous driving, and consumer electronics. It undertakes core research and development functions, including algorithm development, ASIC design, and software systems, supported by a team with extensive industry experience. Black Sesame is committed to scientific and technological innovation, emphasizing quality and integrity in its services. The firm also designs automotive-grade system-on-chip (SoC) solutions, including the Huashan Series for high computing power and the Wudang Series for cross-domain applications, aiming to advance the future of mobility through its technology.
TopOlefin Technology
Series A in 2022
TopOlefin Technology specializes in the research, development, and production of advanced polymer materials, with a focus on high-end optical resins. The company is dedicated to creating products characterized by high transparency, high refractive index, and strong gas barrier properties. These innovative materials find applications across various industries, including optical lenses, medical packaging, and consumer packaging. By prioritizing green and intelligent design, TopOlefin Technology aims to deliver high-quality resin solutions that meet the diverse needs of its clients.
Wangli Technology
Series A in 2021
Wangli Technology is a digital therapy technology platform for mental illness focusing on exploring the field of human brain and spirit.
Yizhun Intelligent
Series C in 2021
Yizhun AI is an artificial intelligence and robotics company focused on developing advanced medical imaging technology. Its primary objective is to enhance the detection of nodules and tumors in the lungs and mammary glands. By leveraging artificial intelligence, Yizhun AI's technology significantly accelerates the identification of malignant entities, thereby assisting healthcare professionals in making accurate diagnoses. Through its innovative solutions, the company aims to improve patient outcomes and streamline the diagnostic process in the medical field.
BestCovered
Series A in 2021
BestCovered is a company focused on developing digital screening tools aimed at early detection and intervention for Alzheimer's disease. By leveraging artificial intelligence technologies, including speech analysis, gesture recognition, and natural language processing, BestCovered creates cognitive impairment risk assessment tools. These tools enable hospitals to achieve high prediction accuracy for Alzheimer's, facilitating timely care for patients. Additionally, BestCovered offers systematic multi-dimensional activation courses designed to help individuals maintain a flexible mind, further contributing to cognitive health and well-being.
LaNova Medicines
Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Vega Technology
Venture Round in 2020
Vega Technology engages in the development of digital intelligent high-end special equipment. The company develops precision CNC, intelligent manufacturing, robot, industrial laser, visual inspection, Internet of things, structure and software design, which are widely used in semiconductor, PCB, SMT, 3C high precision metal processing, and other industrial fields.
Ark Biosciences
Venture Round in 2020
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.
Exegenesis Bio
Seed Round in 2020
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Heyuan Biotechnology
Series C in 2020
Heyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services. They offer gene therapy vectors, gene function research, drug targets, and efficacy for the basic research of gene therapy research, among other services.
BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.
Sigma Squares Tech
Seed Round in 2019
Sigma Squares Tech is a developer of automated manufacturing systems that focuses on industrial automation and computer vision solutions. The company specializes in creating cloud-based vision service platforms and algorithms designed to detect and analyze substantial volumes of industrial data during the manufacturing process. By offering integrated analytical and control solutions, Sigma Squares Tech aims to enhance operational efficiency for small and medium-sized manufacturing companies, enabling them to leverage advanced technology for improved productivity and decision-making.